Latest Insider Transactions at Outset Medical, Inc. (OM)
This section provides a real-time view of insider transactions for Outset Medical, Inc. (OM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Outset Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Outset Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 02
2022
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-0.45%
|
$7,000
$35.0 P/Share
|
May 02
2022
|
Nabeel Ahmed Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.45%
|
$1,800
$9.48 P/Share
|
Apr 21
2022
|
Dale E Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,357
+50.0%
|
-
|
Apr 18
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,415
-3.42%
|
$103,845
$43.25 P/Share
|
Apr 18
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,415
+3.31%
|
$21,735
$9.48 P/Share
|
Apr 01
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
65,000
-6.61%
|
$2,990,000
$46.18 P/Share
|
Apr 01
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+6.95%
|
$150,000
$4.0 P/Share
|
Apr 01
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,000
-8.94%
|
$900,000
$45.78 P/Share
|
Apr 01
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.02%
|
$60,000
$3.88 P/Share
|
Apr 01
2022
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
300
-0.34%
|
$13,500
$45.19 P/Share
|
Apr 01
2022
|
Nabeel Ahmed Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+0.33%
|
$2,700
$9.48 P/Share
|
Mar 24
2022
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
424
-0.94%
|
$17,808
$42.65 P/Share
|
Mar 17
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,400
-3.95%
|
$56,000
$40.46 P/Share
|
Mar 16
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,392
-3.78%
|
$54,288
$39.77 P/Share
|
Mar 16
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,631
-1.17%
|
$141,609
$39.77 P/Share
|
Mar 16
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,030
-2.04%
|
$40,170
$39.77 P/Share
|
Mar 15
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
6,586
-7.91%
|
$250,268
$38.59 P/Share
|
Mar 15
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,586
+7.11%
|
$59,274
$9.48 P/Share
|
Mar 09
2022
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
416
-1.33%
|
$17,056
$41.72 P/Share
|
Mar 09
2022
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
477
-1.05%
|
$19,557
$41.72 P/Share
|
Mar 01
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.01%
|
$215,000
$43.51 P/Share
|
Mar 01
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.26%
|
$40,000
$8.62 P/Share
|
Mar 01
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,003
-2.65%
|
$43,129
$43.73 P/Share
|
Mar 01
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-6.03%
|
$860,000
$43.49 P/Share
|
Mar 01
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.69%
|
$60,000
$3.88 P/Share
|
Feb 15
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
10,002
-11.62%
|
$350,070
$35.92 P/Share
|
Feb 15
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,002
+10.29%
|
$90,018
$9.48 P/Share
|
Feb 02
2022
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,706
+3.63%
|
-
|
Feb 01
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-6.26%
|
$740,000
$37.5 P/Share
|
Feb 01
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+5.89%
|
$60,000
$3.88 P/Share
|
Feb 01
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.01%
|
$185,000
$37.44 P/Share
|
Feb 01
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.26%
|
$40,000
$8.62 P/Share
|
Jan 26
2022
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
48,840
+14.02%
|
-
|
Jan 26
2022
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
24,762
+21.43%
|
-
|
Jan 26
2022
|
Jean Olivier Racine Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,698
+18.78%
|
-
|
Jan 26
2022
|
Stacey L. Porter Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,539
+19.33%
|
-
|
Jan 26
2022
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,888
+20.97%
|
-
|
Jan 26
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,270
+24.44%
|
-
|
Jan 26
2022
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,888
+16.26%
|
-
|
Jan 25
2022
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,280
-5.98%
|
$84,360
$37.74 P/Share
|
Jan 21
2022
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,205
+19.44%
|
-
|
Jan 18
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
10,002
-27.56%
|
$350,070
$35.61 P/Share
|
Jan 18
2022
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,002
+21.27%
|
$90,018
$9.48 P/Share
|
Jan 03
2022
|
Martin Vazquez Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,000
-23.48%
|
$752,000
$47.05 P/Share
|
Jan 03
2022
|
Martin Vazquez Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+18.05%
|
$64,000
$4.02 P/Share
|
Jan 03
2022
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,500
-16.61%
|
$117,500
$47.05 P/Share
|
Jan 03
2022
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
42,500
-5.33%
|
$1,997,500
$47.1 P/Share
|
Jan 03
2022
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+5.04%
|
$127,500
$3.88 P/Share
|
Dec 01
2021
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-3.81%
|
$940,000
$47.24 P/Share
|
Dec 01
2021
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+3.65%
|
$60,000
$3.41 P/Share
|